Skip to main content
OpenTrials
Completed

NCT Number: NCT01296997

Calcium Phosphate and Incretins

The study was conducted to investigate the effect of a calcium phosphate supplementation on the secretion of incretins.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

20 year–35 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Friedrich-Schiller-University Jena, Institute of Nutrition, Department of Nutritional Physiology

Jena, Thuringia, 07743, Germany

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy men

Exclusion criteria

  • intake of dietary supplements and chronic diseases

Treatment and study plan

calcium phosphate

Dietary Supplement

the subjects consumed for 3 weeks a bread enriched with 1 g pentacalcium phosphate per day

Placebo

Other

the subjects consumed a bread without pentacalcium phosphate

Primary outcomes

  1. secretion of incretins

    Time frame: 3 weeks

Secondary outcomes

  1. concentration of minerals in plasma

    Time frame: 3 weeks

Sponsors and collaborators

Lead sponsor

University of Jena

Other

Registry information

Official study title

Influence of a Calcium Phosphate Supplementation on the Secretion of Incretins in Humans.

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Feb 16, 2011
Registry last updated
Nov 7, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.